Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Sheppard

Showing results (371-380 of 430) with videos related to

Pageof 43
Sort By:
Preventive Medicine|July 4, 2021
Measuring the impact of the COVID-19 pandemic on organized cancer screening and diagnostic follow-up care in Ontario, Canada: A provincial, population-based studyMeghan J Walker, Olivia Meggetto, Julia Gao, et al.
The Journal of Infectious Diseases|September 2, 2005
Non-travel-associated hepatitis E in England and Wales: demographic, clinical, and molecular epidemiological characteristicsSamreen Ijaz, Eve Arnold, Malcolm Banks, et al.
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|May 29, 2013
The global nitrogen cycle in the twenty-first centuryDavid Fowler, Mhairi Coyle, Ute Skiba, et al.
Nature Methods|September 11, 2024
Navigate: an open-source platform for smart light-sheet microscopyZach Marin, Xiaoding Wang, Dax W Collison, et al.
International Immunopharmacology|November 9, 2004
Characterization of (2R, 3S)-2-([[4-(2-butynyloxy)phenyl]sulfonyl]amino)-N,3-dihydroxybutanamide, a potent and selective inhibitor of TNF-alpha converting enzymeYuhua Zhang, Martin Hegen, Jun Xu, et al.
ACS Chemical Biology|May 20, 2016
Interrogating the Druggability of the 2-Oxoglutarate-Dependent Dioxygenase Target Class by Chemical ProteomicsGérard Joberty, Markus Boesche, Jack A Brown, et al.
Journal of Medicinal Chemistry|August 1, 2015
Structure-Based Optimization of Naphthyridones into Potent ATAD2 Bromodomain InhibitorsPaul Bamborough, Chun-wa Chung, Rebecca C Furze, et al.
ACS Medicinal Chemistry Letters|November 20, 2014
1,3-Dimethyl Benzimidazolones Are Potent, Selective Inhibitors of the BRPF1 BromodomainEmmanuel H Demont, Paul Bamborough, Chun-Wa Chung, et al.
Angewandte Chemie (International Ed. in English)|August 18, 2016
A Chemical Probe for the ATAD2 BromodomainPaul Bamborough, Chun-Wa Chung, Emmanuel H Demont, et al.
The Lancet. Global Health|November 22, 2024
Lassa fever outbreaks, mathematical models, and disease parameters: a systematic review and meta-analysisPatrick Doohan, David Jorgensen, Tristan M Naidoo, et al.
Pageof 43

Showing results (371-380 of 430) with videos related to

Sort By:
Pageof 43
Preventive Medicine|July 4, 2021
Measuring the impact of the COVID-19 pandemic on organized cancer screening and diagnostic follow-up care in Ontario, Canada: A provincial, population-based studyMeghan J Walker, Olivia Meggetto, Julia Gao, et al.
The Journal of Infectious Diseases|September 2, 2005
Non-travel-associated hepatitis E in England and Wales: demographic, clinical, and molecular epidemiological characteristicsSamreen Ijaz, Eve Arnold, Malcolm Banks, et al.
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|May 29, 2013
The global nitrogen cycle in the twenty-first centuryDavid Fowler, Mhairi Coyle, Ute Skiba, et al.
Nature Methods|September 11, 2024
Navigate: an open-source platform for smart light-sheet microscopyZach Marin, Xiaoding Wang, Dax W Collison, et al.
International Immunopharmacology|November 9, 2004
Characterization of (2R, 3S)-2-([[4-(2-butynyloxy)phenyl]sulfonyl]amino)-N,3-dihydroxybutanamide, a potent and selective inhibitor of TNF-alpha converting enzymeYuhua Zhang, Martin Hegen, Jun Xu, et al.
ACS Chemical Biology|May 20, 2016
Interrogating the Druggability of the 2-Oxoglutarate-Dependent Dioxygenase Target Class by Chemical ProteomicsGérard Joberty, Markus Boesche, Jack A Brown, et al.
Journal of Medicinal Chemistry|August 1, 2015
Structure-Based Optimization of Naphthyridones into Potent ATAD2 Bromodomain InhibitorsPaul Bamborough, Chun-wa Chung, Rebecca C Furze, et al.
ACS Medicinal Chemistry Letters|November 20, 2014
1,3-Dimethyl Benzimidazolones Are Potent, Selective Inhibitors of the BRPF1 BromodomainEmmanuel H Demont, Paul Bamborough, Chun-Wa Chung, et al.
Angewandte Chemie (International Ed. in English)|August 18, 2016
A Chemical Probe for the ATAD2 BromodomainPaul Bamborough, Chun-Wa Chung, Emmanuel H Demont, et al.
The Lancet. Global Health|November 22, 2024
Lassa fever outbreaks, mathematical models, and disease parameters: a systematic review and meta-analysisPatrick Doohan, David Jorgensen, Tristan M Naidoo, et al.
Pageof 43